Tech Company Financing Transactions

Dyno Therapeutics Funding Round

Dyno Therapeutics closed a $9 million Seed venture capital round on 5/15/2020. Backers included CRV, Polaris Partners and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Kendall Sq. Building 1400E 202
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.dynotx.com

Email Address

[email protected]

Overview

Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Alan Crane

        

Chief Executive Officer

Eric Kelsic

        

Co-Founder

Adrian Veres

        

VP - Finance

Andrea Szekely-Hill

        

Browse more venture capital transactions:

Prev: 5/15/2020: Lucid Lane venture capital transaction
Next: 5/15/2020: Hypersonix venture capital transaction

Share this article

About Our Venture Capital Transactions Database

Our team works diligently to document all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary